Registered Uganda · NDA

DOLUTEGRAVIR SODIUM + LAMIVUDINE + TENOFOVIR DISOPROXIL FUMARATE

NDA/MAL/HDP/9322 ORAL SOLID ORDINARY FILM-COATED TABLETS 50 MG + 300 MG + 300 MG

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

NDA/MAL/HDP/9322

Registration date

08/09/2020

Expiry date

Status

Registered

Active ingredient

Dosage form

ORAL SOLID ORDINARY FILM-COATED TABLETS

Strength

50 MG + 300 MG + 300 MG

Pack size

1.0X30.0 TABLET CONTAINER,1.0X90.0 TABLET CONTAINER,1.0X180.0 TABLET CONTAINER

Therapeutic class

Manufacturer / MAH

Cipla Quality Chemical Industries Limited

Applicant / LTR

CIPLA LTD.

Country of origin

UGANDA| INDIA

Source: National Drug Authority · fetched 2026-05-12 08:00:32 · updated 2026-09-12 04:00:21

Disclaimer: This information is sourced from National Drug Authority (Uganda). Always consult a qualified healthcare professional before using any medication.